Skip to content

Clinical trials

Completed Phase 1 Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 1 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20101
20111
20131
20151
20201
20212
20221
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangdong Hengrui Pharmaceutical Co., Ltd2
Guangzhou JOYO Pharma Co., Ltd2
Bristol-Myers Squibb1
Celgene1
Chiesi Farmaceutici S.p.A.1
Endeavor Biomedicines, Inc.1
Gilead Sciences1
Hoffmann-La Roche1
Kyntra Bio1
Mabwell (Shanghai) Bioscience Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis17
Idiopathic Pulmonary Fibrosis7
Lung Diseases4
Fibrosis2
Respiratory Tract Diseases2
Cystic Fibrosis1
Idiopathic Interstitial Pneumonias1
Liver Cirrhosis1
Lung Diseases, Interstitial1
Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.